"I see 2 scenarios for CS Medica, the stock has broken out of a declining trend and there is potential for upside in TP Zone 1 and also TP Zone 2. As mentioned, these are potential thoughts, with many fundamentals also supporting a push, such as the listing of the subsidiary in Germany at a valuation of 30 million euros, while CS is currently valued at 65 million DKK."
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.